Bioteque Total Liabilities
Bioteque total liabilities. Based on the latest financial reports, Bioteque (4107) has total liabilities worth NT$1.35 Billion TWD (≈ $42.62 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 4107 asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Bioteque (2006–2025)
Total liabilities of Bioteque from 2006 to 2025. This chart illustrates how Bioteque's total liabilities have evolved over time, based on quarterly financial data. Explore Bioteque (4107) long-term investment share to see how much of total assets are deployed in long-term investments.
Bioteque Competitors by Total Liabilities
The table below lists competitors of Bioteque ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Central Omega Resources Tbk PT
JK:DKFT
|
Indonesia | Rp1.84 Trillion |
|
Vanda Pharmaceuticals Inc
NASDAQ:VNDA
|
USA | $161.76 Million |
|
Sarana Meditama Metropolitan
JK:SAME
|
Indonesia | Rp1.51 Trillion |
|
Viking Supply Ships AB (publ)
ST:VSSAB-B
|
Sweden | Skr1.73 Billion |
|
Genesis Technology
TWO:6221
|
Taiwan | NT$2.80 Billion |
|
ACELYRIN, INC. Common Stock
NASDAQ:SLRN
|
USA | $29.27 Million |
|
BCEG Environmental Remediation Co. Ltd.
SHE:300958
|
China | CN¥1.39 Billion |
|
Hawthorn Bancshares Inc
NASDAQ:HWBK
|
USA | $1.72 Billion |
Liability Composition Analysis (2006–2025)
This chart breaks down Bioteque's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Bioteque (4107) total assets.
Liquidity & Leverage Metrics
Bioteque Total Liabilities Ratios Explained
Bioteque total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.75 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Bioteque's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Bioteque (2006–2025)
The table below shows the annual total liabilities of Bioteque from 2006 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.05 Billion ≈ $33.17 Million |
-12.59% |
| 2024-12-31 | NT$1.20 Billion ≈ $37.95 Million |
-15.79% |
| 2023-12-31 | NT$1.43 Billion ≈ $45.06 Million |
-1.26% |
| 2022-12-31 | NT$1.45 Billion ≈ $45.64 Million |
+36.95% |
| 2021-12-31 | NT$1.06 Billion ≈ $33.32 Million |
+17.58% |
| 2020-12-31 | NT$899.55 Million ≈ $28.34 Million |
+98.85% |
| 2019-12-31 | NT$452.37 Million ≈ $14.25 Million |
-1.12% |
| 2018-12-31 | NT$457.51 Million ≈ $14.41 Million |
-5.61% |
| 2017-12-31 | NT$484.69 Million ≈ $15.27 Million |
-0.35% |
| 2016-12-31 | NT$486.40 Million ≈ $15.32 Million |
-19.75% |
| 2015-12-31 | NT$606.13 Million ≈ $19.10 Million |
+30.29% |
| 2014-12-31 | NT$465.21 Million ≈ $14.66 Million |
+22.08% |
| 2013-12-31 | NT$381.06 Million ≈ $12.01 Million |
+11.13% |
| 2012-12-31 | NT$342.89 Million ≈ $10.80 Million |
-11.48% |
| 2011-12-31 | NT$387.34 Million ≈ $12.20 Million |
-12.33% |
| 2010-12-31 | NT$441.82 Million ≈ $13.92 Million |
-6.84% |
| 2009-12-31 | NT$474.29 Million ≈ $14.94 Million |
-11.44% |
| 2008-12-31 | NT$535.56 Million ≈ $16.87 Million |
+11.95% |
| 2007-12-31 | NT$478.39 Million ≈ $15.07 Million |
-9.85% |
| 2006-12-31 | NT$530.68 Million ≈ $16.72 Million |
-- |
About Bioteque
Bioteque Corporation manufactures and sells medical devices in Asia, South America, North America, and internationally. The company offers angiography catheter, balloon dilation catheter, guiding sheath, guide steel wire, y-type connector, multi-pipe joint, connecting pipe, y-type connector assembly, peripheral vascular guiding catheter, coronary balloon dilation catheter, central venous catheter… Read more